Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBT Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBT Margin for 2 consecutive years, with 5514.74% as the latest value for Q1 2024.

  • On a quarterly basis, EBT Margin changed N/A to 5514.74% in Q1 2024 year-over-year; TTM through Dec 2024 was 24675.3%, a N/A change, with the full-year FY2024 number at 26045.02%, down 2595800.0% from a year prior.
  • EBT Margin was 5514.74% for Q1 2024 at Artiva Biotherapeutics, down from 639.3% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 639.3% in Q4 2023 to a low of 5514.74% in Q1 2024.